apremilast

It is used for the treatment of adults with active psoriatic arthritis (if other medicines are not effective or cannot be used), moderate to severe chronic plaque psoriasis, and for mouth ulcers caused by Behçet's disease. It is also indicated for children and adolescents aged 6 years and older (with a minimum weight of 20 kg) suffering from moderate to severe plaque psoriasis.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: ACCORD HEALTHCARE, S.L.U.

It is used for the treatment of adults with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and for the treatment of mouth ulcers in patients with Behçet's disease.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: DAY ZERO EHF

It is used for the treatment of adults with active psoriatic arthritis, chronic moderate-to-severe plaque psoriasis, and Behçet's disease (for mouth ulcers). It is also indicated for children and adolescents aged 6 years and older with a minimum weight of 20 kg for moderate-to-severe plaque psoriasis.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: EG S.P.A.

It is used to treat active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and mouth ulcers caused by Behçet's disease in adults.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: G.L. PHARMA GMBH

It is used for the treatment of adults with active psoriatic arthritis, chronic moderate to severe plaque psoriasis, and for the treatment of mouth ulcers in people with Behçet's disease.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: KRKA D.D. NOVO MESTO

It is used to treat active psoriatic arthritis in adults, chronic moderate-to-severe plaque psoriasis in adults and children/adolescents (from 6 years of age with a minimum weight of 20 kg), and Behçet's disease (for mouth ulcers) in adults.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: MACLEODS PHARMA ESPANA, S.L.U.

It is used for the treatment of adults with active psoriatic arthritis, moderate to severe plaque psoriasis, and to treat oral ulcers caused by Behçet's disease.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: NOUCOR HEALTH, S.A.

It is used for the treatment of adults with active psoriatic arthritis, chronic moderate-to-severe plaque psoriasis, and for mouth ulcers caused by Behçet's disease.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: SANDOZ S.P.A.

It is used for the treatment of three diseases in adults: active psoriatic arthritis (if other medicines are not effective), chronic moderate-to-severe plaque psoriasis (if other treatments such as phototherapy or systemic therapies are not effective), and Behçet's disease, specifically for the treatment of mouth ulcers.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: SANDOZ GMBH

It is used to treat adults with active psoriatic arthritis, chronic moderate-to-severe plaque psoriasis, and for the treatment of mouth ulcers in patients with Behçet's disease.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: TEVA ITALIA S.R.L.

It is used for the treatment of adults with active psoriatic arthritis, chronic moderate-to-severe plaque psoriasis, and Behçet's disease (for mouth ulcers). It is also indicated for children and adolescents aged 6 years and older (with a minimum weight of 20 kg) suffering from plaque psoriasis.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: ZENTIVA ITALIA S.R.L.

Otezla is used for the treatment of adults with active psoriatic arthritis, chronic moderate-to-severe plaque psoriasis, and Behçet's disease (for mouth ulcers). It is also indicated for children and adolescents aged 6 years and older weighing at least 20 kg for the treatment of moderate-to-severe plaque psoriasis.

Form: tablets, film-coated

ATC: L04AA32

Manufacturer: AMGEN EUROPE B.V.